Roche Appoints Dan Malarek as CEO of Diagnostics North America

Roche has appointed Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026. This leadership change is part of a broader restructuring that includes the creation of a new Chief Commercial Officer role for its U.S. diagnostics business.

By Fiona Craig Mon, July 20, 2026 at 5:56 PM GMT+3 2 min read · Yahoo Finance · July 20, 2026, 14:56 UTC

Roche Appoints Dan Malarek as CEO of Diagnostics North America

Tickers: $ROP

Topics: CEO appointment Diagnostics North America Foundation Medicine Roche

Read the full article at Yahoo Finance

More World news

Moderna Shares Decline Following Analyst Day Projections and Future Cost Concerns Motley Fool · November 12, 2026, 17:13 UTC
United Airlines Restricts AI Agent Access to Booking Systems Due to Cybersecurity and Regulatory Concerns TechCrunch · November 12, 2026, 17:17 UTC
Global Payments Shares Drop 12% Following Reports Private Equity Firms Abandoned Takeover Bid Seeking Alpha · November 12, 2026, 17:14 UTC
Nvidia Appoints Colette Kress as Interim CEO Following Jensen Huang's Resignation CNBC · November 12, 2026, 16:59 UTC
Brookfield Corporation Reports Strong Third Quarter Earnings Growth and Increased Share Buybacks Motley Fool · November 12, 2026, 17:08 UTC
Franco-Nevada Reports Q3 2026 Revenue Growth Driven by Higher Gold and Oil Prices Motley Fool · November 12, 2026, 17:10 UTC
Stratasys Reports Q3 2026 Revenue Growth Driven by Aerospace and Defense Demand Motley Fool · November 12, 2026, 17:11 UTC
Jim Cramer Advises Profit-Taking Following Jensen Huang's Resignation at Nvidia CNBC · November 12, 2026, 16:59 UTC
LexisNexis Report Shows Elevated U.S. Auto Insurance Shopping Volumes in Q3 2026 PR Newswire · November 12, 2026, 17:12 UTC
Suburban Propane Partners Outlines $60M-$70M Capital Expenditures for Fiscal 2027 Seeking Alpha · November 12, 2026, 17:00 UTC